Skip to main content
Equibles

VANGUARD FIDUCIARY TRUST CO

Bank

Position in GNLX — GENELUX Corp

CIK 933478 MALVERN, PA
Back to GNLX Full portfolio

Position in GNLX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$711,395
+$102,499 QoQ
Shares Held
236,344
-6.1% QoQ
Ownership
0.522%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 72 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VANGUARD FIDUCIARY TRUST CO holds $5,609,342,606 across 467 Biotechnology names. GNLX ranks #280 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,425,390 $708,033,974
2 REGN
Regeneron Pharmaceuticals, Inc.
 563,711 $351,496,356
3 ALNY
Alnylam Pharmaceuticals, Inc.
 862,782 $259,723,265
4 RVMD
Revolution Medicines, Inc.
 1,291,141 $241,804,886
5 INSM
INSMED Inc
 1,401,552 $149,433,474
6 MRNA
Moderna, Inc.
 1,987,627 $139,193,518
7 RPRX
Royalty Pharma plc
 2,163,271 $121,294,604
8 INCY
Incyte Corp
 943,540 $106,959,694

All Filings in GNLX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $711,395 236,344
2026-03-31 $608,896 251,610